FIELD: medicine, in particular pulmonology.
SUBSTANCE: claimed method includes administration of 5 roncoleukine inhalation on alternate day in dose of 0.25 mlnIU, diluted in 3 ml of physiologic solution through compression nebuliser. After the third roncoleukine inhalation inductometry on lung roots is carried out for 15-70 min every day, 7 procedures in total.
EFFECT: normal levels of systemic and local anti-inflammatory cytokines; decreased course of antibacterial therapy.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING PATIENTS FOR BRONCHOPULMONARY PNEUMONIA | 2002 |
|
RU2205659C1 |
METHOD FOR DETERMINING COMMUNITY-ACQUIRED PNEUMONIA CLINICAL COURSE SEVERITY DEGREE | 2005 |
|
RU2302637C1 |
METHOD FOR PREDICTION OF COMPLICATED COURSE OF COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN | 2015 |
|
RU2603476C1 |
METHOD OF TREATMENT OF STEROID-DEPENDENT BRONCHIAL ASTHMA | 2007 |
|
RU2348431C1 |
METHOD OF TREATING SCHIZOPHRENIA | 2011 |
|
RU2484836C2 |
METHOD FOR COMMUNITY-ACQUIRED PNEUMONIA TREATMENT | 2015 |
|
RU2611414C1 |
INTEGRATED THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA | 2008 |
|
RU2375060C1 |
METHOD FOR DETERMINATION OF CYTOKINES AND IMMUNOGLOBULIN E IN EXPIRED MOISTURE CONDENSATE | 2002 |
|
RU2222015C1 |
METHOD OF TREATING BRONCHOPULMONARY DISEASES | 2018 |
|
RU2695366C1 |
METHOD OF TREATING INFLUENZA AND INFLUENZA-LIKE ILLNESSES COMPLICATED WITH PNEUMONIA | 2012 |
|
RU2518277C2 |
Authors
Dates
2007-09-10—Published
2006-02-16—Filed